Medroxyprogesterone acetate and cancer cachexia: Interleukin-6 involvement

Breast Cancer ◽  
2000 ◽  
Vol 7 (2) ◽  
pp. 130-135 ◽  
Author(s):  
Jun-ichi Yamashita ◽  
Michio Ogawa
Keyword(s):  
Medroxyprogesterone Acetate ◽  
Interleukin 6 ◽  
Cancer Cachexia

scholarly journals Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning

2018 ◽  
Vol 17 (1) ◽  
Author(s):  
Jun Han ◽  
Qingyang Meng ◽  
Lei Shen ◽  
Guohao Wu
Keyword(s):  
Adipose Tissue ◽  
White Adipose Tissue ◽  
Interleukin 6 ◽  
Cancer Cachexia ◽  
Fat Loss ◽  
Adipose Tissue Lipolysis

Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: Possible cellular mechanisms of cancer cachexia

1996 ◽  
Vol 3 (1) ◽  
pp. 29-35 ◽  
Author(s):  
Kevin G. Billingsley ◽  
Douglas L. Fraker ◽  
Gideon Strassmann ◽  
Caroline Loeser ◽  
Helen M. Fliot ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Interleukin 6 ◽  
Leukemia Inhibitory Factor ◽  
Tumor Necrosis ◽  
Cancer Cachexia ◽  
Inhibitory Factor ◽  
Cellular Mechanisms ◽  
Necrosis Factor

Medroxyprogesterone Acetate in Cancer Cachexia

2007 ◽  
pp. 649-652
Author(s):  
Giorgio Lelli ◽  
Benedetta Urbini ◽  
Daniela Scapoli ◽  
Germana Gilli
Keyword(s):  
Medroxyprogesterone Acetate ◽  
Cancer Cachexia

Clinical benefit of palliative treatment of cancer cachexia with medroxyprogesterone acetate (MPA)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 8213-8213
Author(s):  
D. Tassinari ◽  
E. Flamini ◽  
B. Poggi ◽  
F. Fochessati ◽  
M. Fantini ◽  
...  
Keyword(s):  
Medroxyprogesterone Acetate ◽  
Clinical Benefit ◽  
Palliative Treatment ◽  
Cancer Cachexia

scholarly journals Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

1992 ◽  
Vol 89 (5) ◽  
pp. 1681-1684 ◽  
Author(s):  
G Strassmann ◽  
M Fong ◽  
J S Kenney ◽  
C O Jacob
Keyword(s):  
Interleukin 6 ◽  
Cancer Cachexia ◽  
Experimental Cancer

Clinical benefit of palliative treatment of cancer cachexia with medroxyprogesterone acetate (MPA)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 8213-8213
Author(s):  
D. Tassinari ◽  
E. Flamini ◽  
B. Poggi ◽  
F. Fochessati ◽  
M. Fantini ◽  
...  
Keyword(s):  
Medroxyprogesterone Acetate ◽  
Clinical Benefit ◽  
Palliative Treatment ◽  
Cancer Cachexia

Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma

Cancer ◽  
1996 ◽  
Vol 78 (11) ◽  
pp. 2346-2352 ◽  
Author(s):  
Jun-ichi Yamashita ◽  
Teru Hideshima ◽  
Takayuki Shirakusa ◽  
Michio Ogawa
Keyword(s):  
Breast Carcinoma ◽  
Medroxyprogesterone Acetate ◽  
Interleukin 6 ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma

Possible Role for Tocilizumab, an Anti–Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia

2013 ◽  
Vol 31 (6) ◽  
pp. e69-e72 ◽  
Author(s):  
Katsutoshi Ando ◽  
Fumiyuki Takahashi ◽  
Shinji Motojima ◽  
Kei Nakashima ◽  
Norihiro Kaneko ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Cancer Cachexia ◽  
Receptor Antibody ◽  
Interleukin 6 Receptor
Sign in / Sign up

Export Citation Format

Share Document